Literature DB >> 3100939

Isolation and purification of two human liver UDP-glucuronosyltransferases.

Y M Irshaid, T R Tephly.   

Abstract

Two UDP-glucuronosyltransferases (EC 2.4.1.17) were purified from human liver microsomes. Human liver microsomes were solubilized with Emulgen 911 and the UDP-glucuronosyltransferases were separated and purified by chromatofocusing and UDP-hexanolamine Sepharose 4B affinity chromatography. One isoenzyme eluted with an apparent pl of 7.4, displayed a subunit molecular weight of 53,000 after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and catalyzed the glucuronidation of p-nitrophenol, 4-methylumbelliferone, alpha-naphthylamine, and estriol, but not that of 4-aminobiphenyl. A second isoenzyme eluted with an apparent pl of 6.2, displayed a subunit molecular weight of 54,000 after SDS-PAGE, and catalyzed the glucuronidation of p-nitrophenol, 4-methylumbelliferone, alpha-naphthylamine, and 4-aminobiphenyl, but not that of estriol. Neither of the purified human liver UDP-glucuronosyltransferases employed estrone, beta-estradiol, testosterone, androsterone, or 5 alpha-androstane-3 alpha,17 beta-diol as substrate. These enzymes displayed apparent Km values in the same order of magnitude for a given substrate. In general, high concentrations of phosphatidylcholine were required for reconstitution of maximal glucuronidation activity. This report documents the existence of multiple UDP-glucuronosyltransferases in human liver.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100939

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family.

Authors:  R Wooster; L Sutherland; T Ebner; D Clarke; O Da Cruz e Silva; B Burchell
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

2.  Multiplicity of UDP-glucuronosyltransferases in fish. Purification and characterization of a phenol UDP-glucuronosyltransferase from the liver of a marine teleost, Pleuronectes platessa.

Authors:  D J Clarke; S G George; B Burchell
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I.

Authors:  H H van Es; B G Goldhoorn; M Paul-Abrahamse; R P Elferink; P L Jansen
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Cloning and substrate specificity of a human phenol UDP-glucuronosyltransferase expressed in COS-7 cells.

Authors:  D Harding; S Fournel-Gigleux; M R Jackson; B Burchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

6.  Glucuronidation of 7-hydroxy-4-methylcoumarin by human liver microsomes. Inhibition by certain drugs.

Authors:  Y M Irshaid; K I Gharaybeh; F F Ammari; N M Rawashdeh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

7.  Hydroxysteroid sulfotransferase and a specific UDP-glucuronosyltransferase are involved in the metabolism of digitoxin in man.

Authors:  A Schmoldt; I Blömer; A Johannes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

8.  Human liver budesonide sulphotransferase is inhibited by testosterone and correlates with by testosterone sulphotransferase.

Authors:  G M Pacifici; M A Ferroni; A Temellini; A Gucci; M C Morelli; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.

Authors:  F F Kadlubar; M A Butler; K R Kaderlik; H C Chou; N P Lang
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.